nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2C8—Sorafenib—liver cancer	0.0972	0.191	CbGbCtD
Propafenone—CYP1A2—Sorafenib—liver cancer	0.0753	0.148	CbGbCtD
Propafenone—CYP2C9—Sorafenib—liver cancer	0.0678	0.133	CbGbCtD
Propafenone—ABCB1—Sorafenib—liver cancer	0.0658	0.129	CbGbCtD
Propafenone—CYP2D6—Sorafenib—liver cancer	0.062	0.122	CbGbCtD
Propafenone—ABCB1—Doxorubicin—liver cancer	0.0399	0.0785	CbGbCtD
Propafenone—CYP3A4—Sorafenib—liver cancer	0.0394	0.0775	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—liver cancer	0.0376	0.0739	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—liver cancer	0.0239	0.047	CbGbCtD
Propafenone—Benazepril—MTHFR—liver cancer	0.00179	0.305	CrCbGaD
Propafenone—Carvedilol—VEGFA—liver cancer	0.00136	0.231	CrCbGaD
Propafenone—Mirabegron—ALB—liver cancer	0.000908	0.155	CrCbGaD
Propafenone—Carvedilol—CYP2E1—liver cancer	0.000665	0.113	CrCbGaD
Propafenone—Carvedilol—CYP1A1—liver cancer	0.000656	0.112	CrCbGaD
Propafenone—Purpura—Doxorubicin—liver cancer	0.000583	0.00168	CcSEcCtD
Propafenone—Asthenia—Sorafenib—liver cancer	0.00058	0.00167	CcSEcCtD
Propafenone—Cardiac arrest—Epirubicin—liver cancer	0.000578	0.00166	CcSEcCtD
Propafenone—Cardiac failure—Doxorubicin—liver cancer	0.000576	0.00166	CcSEcCtD
Propafenone—Cerebrovascular accident—Doxorubicin—liver cancer	0.000574	0.00165	CcSEcCtD
Propafenone—Pruritus—Sorafenib—liver cancer	0.000572	0.00165	CcSEcCtD
Propafenone—Ataxia—Epirubicin—liver cancer	0.000571	0.00164	CcSEcCtD
Propafenone—Blood creatinine increased—Epirubicin—liver cancer	0.000569	0.00164	CcSEcCtD
Propafenone—Dehydration—Epirubicin—liver cancer	0.000565	0.00163	CcSEcCtD
Propafenone—Hyponatraemia—Doxorubicin—liver cancer	0.000565	0.00162	CcSEcCtD
Propafenone—Osteoarthritis—Doxorubicin—liver cancer	0.000562	0.00162	CcSEcCtD
Propafenone—Liver function test abnormal—Epirubicin—liver cancer	0.000561	0.00161	CcSEcCtD
Propafenone—Dry skin—Epirubicin—liver cancer	0.000557	0.0016	CcSEcCtD
Propafenone—Orthostatic hypotension—Epirubicin—liver cancer	0.000555	0.0016	CcSEcCtD
Propafenone—Hypokalaemia—Epirubicin—liver cancer	0.000553	0.00159	CcSEcCtD
Propafenone—Diarrhoea—Sorafenib—liver cancer	0.000553	0.00159	CcSEcCtD
Propafenone—Breast disorder—Epirubicin—liver cancer	0.000549	0.00158	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000547	0.00157	CcSEcCtD
Propafenone—Gastritis—Epirubicin—liver cancer	0.000538	0.00155	CcSEcCtD
Propafenone—Muscular weakness—Epirubicin—liver cancer	0.000536	0.00154	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000536	0.00154	CcSEcCtD
Propafenone—Cardiac arrest—Doxorubicin—liver cancer	0.000535	0.00154	CcSEcCtD
Propafenone—Dizziness—Sorafenib—liver cancer	0.000535	0.00154	CcSEcCtD
Propafenone—Abdominal distension—Epirubicin—liver cancer	0.000529	0.00152	CcSEcCtD
Propafenone—Ataxia—Doxorubicin—liver cancer	0.000529	0.00152	CcSEcCtD
Propafenone—Blood creatinine increased—Doxorubicin—liver cancer	0.000527	0.00152	CcSEcCtD
Propafenone—Influenza—Epirubicin—liver cancer	0.000525	0.00151	CcSEcCtD
Propafenone—Dysphagia—Epirubicin—liver cancer	0.000525	0.00151	CcSEcCtD
Propafenone—Dehydration—Doxorubicin—liver cancer	0.000523	0.0015	CcSEcCtD
Propafenone—Eosinophilia—Epirubicin—liver cancer	0.00052	0.0015	CcSEcCtD
Propafenone—Liver function test abnormal—Doxorubicin—liver cancer	0.000519	0.00149	CcSEcCtD
Propafenone—Dry skin—Doxorubicin—liver cancer	0.000515	0.00148	CcSEcCtD
Propafenone—Pancreatitis—Epirubicin—liver cancer	0.000515	0.00148	CcSEcCtD
Propafenone—Vomiting—Sorafenib—liver cancer	0.000514	0.00148	CcSEcCtD
Propafenone—Orthostatic hypotension—Doxorubicin—liver cancer	0.000514	0.00148	CcSEcCtD
Propafenone—Hypokalaemia—Doxorubicin—liver cancer	0.000512	0.00147	CcSEcCtD
Propafenone—Angina pectoris—Epirubicin—liver cancer	0.000512	0.00147	CcSEcCtD
Propafenone—Rash—Sorafenib—liver cancer	0.00051	0.00147	CcSEcCtD
Propafenone—Dermatitis—Sorafenib—liver cancer	0.000509	0.00146	CcSEcCtD
Propafenone—Breast disorder—Doxorubicin—liver cancer	0.000508	0.00146	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000506	0.00146	CcSEcCtD
Propafenone—Headache—Sorafenib—liver cancer	0.000506	0.00146	CcSEcCtD
Propafenone—Propranolol—CYP1A1—liver cancer	0.000499	0.0849	CrCbGaD
Propafenone—Gastritis—Doxorubicin—liver cancer	0.000498	0.00143	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000496	0.00143	CcSEcCtD
Propafenone—Muscular weakness—Doxorubicin—liver cancer	0.000496	0.00143	CcSEcCtD
Propafenone—Dysuria—Epirubicin—liver cancer	0.000491	0.00141	CcSEcCtD
Propafenone—Abdominal distension—Doxorubicin—liver cancer	0.000489	0.00141	CcSEcCtD
Propafenone—Upper respiratory tract infection—Epirubicin—liver cancer	0.000488	0.0014	CcSEcCtD
Propafenone—Influenza—Doxorubicin—liver cancer	0.000486	0.0014	CcSEcCtD
Propafenone—Dysphagia—Doxorubicin—liver cancer	0.000486	0.0014	CcSEcCtD
Propafenone—Pollakiuria—Epirubicin—liver cancer	0.000485	0.0014	CcSEcCtD
Propafenone—Eosinophilia—Doxorubicin—liver cancer	0.000481	0.00138	CcSEcCtD
Propafenone—Nausea—Sorafenib—liver cancer	0.00048	0.00138	CcSEcCtD
Propafenone—Weight increased—Epirubicin—liver cancer	0.000478	0.00138	CcSEcCtD
Propafenone—Pancreatitis—Doxorubicin—liver cancer	0.000477	0.00137	CcSEcCtD
Propafenone—Weight decreased—Epirubicin—liver cancer	0.000475	0.00137	CcSEcCtD
Propafenone—Hyperglycaemia—Epirubicin—liver cancer	0.000474	0.00136	CcSEcCtD
Propafenone—Angina pectoris—Doxorubicin—liver cancer	0.000473	0.00136	CcSEcCtD
Propafenone—Infestation NOS—Epirubicin—liver cancer	0.000468	0.00135	CcSEcCtD
Propafenone—Infestation—Epirubicin—liver cancer	0.000468	0.00135	CcSEcCtD
Propafenone—Drowsiness—Epirubicin—liver cancer	0.000468	0.00135	CcSEcCtD
Propafenone—Renal failure—Epirubicin—liver cancer	0.00046	0.00132	CcSEcCtD
Propafenone—Neuropathy peripheral—Epirubicin—liver cancer	0.000459	0.00132	CcSEcCtD
Propafenone—Stomatitis—Epirubicin—liver cancer	0.000457	0.00131	CcSEcCtD
Propafenone—Jaundice—Epirubicin—liver cancer	0.000457	0.00131	CcSEcCtD
Propafenone—Dysuria—Doxorubicin—liver cancer	0.000454	0.00131	CcSEcCtD
Propafenone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000452	0.0013	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—liver cancer	0.000449	0.00129	CcSEcCtD
Propafenone—Haematuria—Epirubicin—liver cancer	0.000447	0.00128	CcSEcCtD
Propafenone—Hepatobiliary disease—Epirubicin—liver cancer	0.000443	0.00127	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—liver cancer	0.000442	0.00127	CcSEcCtD
Propafenone—Epistaxis—Epirubicin—liver cancer	0.000442	0.00127	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—liver cancer	0.00044	0.00127	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—liver cancer	0.000438	0.00126	CcSEcCtD
Propafenone—Agranulocytosis—Epirubicin—liver cancer	0.000437	0.00126	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—liver cancer	0.000433	0.00125	CcSEcCtD
Propafenone—Infestation—Doxorubicin—liver cancer	0.000433	0.00125	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—liver cancer	0.000433	0.00125	CcSEcCtD
Propafenone—Bradycardia—Epirubicin—liver cancer	0.000428	0.00123	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—liver cancer	0.000426	0.00123	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—liver cancer	0.000425	0.00122	CcSEcCtD
Propafenone—Haemoglobin—Epirubicin—liver cancer	0.000423	0.00122	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—liver cancer	0.000422	0.00122	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—liver cancer	0.000422	0.00122	CcSEcCtD
Propafenone—Rhinitis—Epirubicin—liver cancer	0.000422	0.00121	CcSEcCtD
Propafenone—Haemorrhage—Epirubicin—liver cancer	0.00042	0.00121	CcSEcCtD
Propafenone—Hepatitis—Epirubicin—liver cancer	0.00042	0.00121	CcSEcCtD
Propafenone—Hypoaesthesia—Epirubicin—liver cancer	0.000418	0.0012	CcSEcCtD
Propafenone—Urinary tract disorder—Epirubicin—liver cancer	0.000415	0.00119	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—liver cancer	0.000413	0.00119	CcSEcCtD
Propafenone—Connective tissue disorder—Epirubicin—liver cancer	0.000413	0.00119	CcSEcCtD
Propafenone—Urethral disorder—Epirubicin—liver cancer	0.000412	0.00119	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—liver cancer	0.00041	0.00118	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—liver cancer	0.000409	0.00118	CcSEcCtD
Propafenone—Visual impairment—Epirubicin—liver cancer	0.000405	0.00117	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—liver cancer	0.000404	0.00116	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—liver cancer	0.000396	0.00114	CcSEcCtD
Propafenone—Eye disorder—Epirubicin—liver cancer	0.000393	0.00113	CcSEcCtD
Propafenone—Tinnitus—Epirubicin—liver cancer	0.000392	0.00113	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—liver cancer	0.000391	0.00112	CcSEcCtD
Propafenone—Cardiac disorder—Epirubicin—liver cancer	0.00039	0.00112	CcSEcCtD
Propafenone—Flushing—Epirubicin—liver cancer	0.00039	0.00112	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—liver cancer	0.00039	0.00112	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—liver cancer	0.000389	0.00112	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—liver cancer	0.000389	0.00112	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—liver cancer	0.000387	0.00111	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—liver cancer	0.000384	0.00111	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—liver cancer	0.000382	0.0011	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—liver cancer	0.000381	0.0011	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—liver cancer	0.000381	0.0011	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—liver cancer	0.00038	0.00109	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—liver cancer	0.000379	0.00109	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—liver cancer	0.000376	0.00108	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—liver cancer	0.000375	0.00108	CcSEcCtD
Propafenone—Alopecia—Epirubicin—liver cancer	0.000372	0.00107	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—liver cancer	0.000368	0.00106	CcSEcCtD
Propafenone—Erythema—Epirubicin—liver cancer	0.000366	0.00105	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—liver cancer	0.000366	0.00105	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—liver cancer	0.000364	0.00105	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—liver cancer	0.000363	0.00104	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—liver cancer	0.000361	0.00104	CcSEcCtD
Propafenone—Flushing—Doxorubicin—liver cancer	0.000361	0.00104	CcSEcCtD
Propafenone—Flatulence—Epirubicin—liver cancer	0.000361	0.00104	CcSEcCtD
Propafenone—Tension—Epirubicin—liver cancer	0.000359	0.00103	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—liver cancer	0.000358	0.00103	CcSEcCtD
Propafenone—Nervousness—Epirubicin—liver cancer	0.000355	0.00102	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—liver cancer	0.000353	0.00102	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—liver cancer	0.000352	0.00101	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—liver cancer	0.000351	0.00101	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—liver cancer	0.000351	0.00101	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—liver cancer	0.000348	0.001	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—liver cancer	0.000345	0.000992	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—liver cancer	0.000344	0.000989	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—liver cancer	0.000341	0.000981	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—liver cancer	0.00034	0.000977	CcSEcCtD
Propafenone—Erythema—Doxorubicin—liver cancer	0.000339	0.000974	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—liver cancer	0.000339	0.000974	CcSEcCtD
Propafenone—Anaemia—Epirubicin—liver cancer	0.000338	0.000973	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—liver cancer	0.000334	0.00096	CcSEcCtD
Propafenone—Tension—Doxorubicin—liver cancer	0.000332	0.000956	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—liver cancer	0.000332	0.000954	CcSEcCtD
Propafenone—Malaise—Epirubicin—liver cancer	0.00033	0.00095	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—liver cancer	0.000329	0.000946	CcSEcCtD
Propafenone—Vertigo—Epirubicin—liver cancer	0.000329	0.000946	CcSEcCtD
Propafenone—Syncope—Epirubicin—liver cancer	0.000328	0.000944	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—liver cancer	0.000328	0.000943	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—liver cancer	0.000326	0.000937	CcSEcCtD
Propafenone—Palpitations—Epirubicin—liver cancer	0.000323	0.000931	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—liver cancer	0.000322	0.000925	CcSEcCtD
Propafenone—Cough—Epirubicin—liver cancer	0.000319	0.000919	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—liver cancer	0.000319	0.000918	CcSEcCtD
Propafenone—Convulsion—Epirubicin—liver cancer	0.000317	0.000912	CcSEcCtD
Propafenone—Hypertension—Epirubicin—liver cancer	0.000316	0.000909	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—liver cancer	0.000314	0.000904	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—liver cancer	0.000313	0.000901	CcSEcCtD
Propafenone—Myalgia—Epirubicin—liver cancer	0.000312	0.000896	CcSEcCtD
Propafenone—Chest pain—Epirubicin—liver cancer	0.000312	0.000896	CcSEcCtD
Propafenone—Anxiety—Epirubicin—liver cancer	0.000311	0.000893	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000309	0.00089	CcSEcCtD
Propafenone—Discomfort—Epirubicin—liver cancer	0.000308	0.000886	CcSEcCtD
Propafenone—Malaise—Doxorubicin—liver cancer	0.000305	0.000879	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—liver cancer	0.000305	0.000877	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—liver cancer	0.000304	0.000875	CcSEcCtD
Propafenone—Syncope—Doxorubicin—liver cancer	0.000304	0.000874	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—liver cancer	0.000303	0.000872	CcSEcCtD
Propafenone—Confusional state—Epirubicin—liver cancer	0.000301	0.000867	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—liver cancer	0.000299	0.000861	CcSEcCtD
Propafenone—Oedema—Epirubicin—liver cancer	0.000299	0.000859	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—liver cancer	0.000298	0.000856	CcSEcCtD
Propafenone—Infection—Epirubicin—liver cancer	0.000297	0.000854	CcSEcCtD
Propafenone—Cough—Doxorubicin—liver cancer	0.000296	0.00085	CcSEcCtD
Propafenone—Shock—Epirubicin—liver cancer	0.000294	0.000845	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—liver cancer	0.000293	0.000844	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—liver cancer	0.000293	0.000843	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—liver cancer	0.000292	0.000841	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—liver cancer	0.000292	0.000841	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—liver cancer	0.000292	0.000839	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—liver cancer	0.00029	0.000835	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—liver cancer	0.000289	0.000831	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—liver cancer	0.000288	0.000829	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—liver cancer	0.000288	0.000829	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—liver cancer	0.000287	0.000827	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000286	0.000824	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—liver cancer	0.000285	0.00082	CcSEcCtD
Propafenone—Anorexia—Epirubicin—liver cancer	0.000285	0.000819	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—liver cancer	0.000282	0.000811	CcSEcCtD
Propafenone—Hypotension—Epirubicin—liver cancer	0.000279	0.000803	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—liver cancer	0.000279	0.000802	CcSEcCtD
Propafenone—Oedema—Doxorubicin—liver cancer	0.000276	0.000795	CcSEcCtD
Propafenone—Infection—Doxorubicin—liver cancer	0.000275	0.00079	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000272	0.000783	CcSEcCtD
Propafenone—Shock—Doxorubicin—liver cancer	0.000272	0.000782	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—liver cancer	0.000271	0.00078	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—liver cancer	0.000271	0.000779	CcSEcCtD
Propafenone—Insomnia—Epirubicin—liver cancer	0.00027	0.000777	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—liver cancer	0.00027	0.000776	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—liver cancer	0.000268	0.000772	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—liver cancer	0.000268	0.000772	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—liver cancer	0.000267	0.000769	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—liver cancer	0.000266	0.000766	CcSEcCtD
Propafenone—Somnolence—Epirubicin—liver cancer	0.000266	0.000764	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—liver cancer	0.000263	0.000758	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—liver cancer	0.000263	0.000756	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—liver cancer	0.00026	0.000747	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—liver cancer	0.000258	0.000743	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000258	0.000742	CcSEcCtD
Propafenone—Fatigue—Epirubicin—liver cancer	0.000258	0.000741	CcSEcCtD
Propafenone—Pain—Epirubicin—liver cancer	0.000255	0.000735	CcSEcCtD
Propafenone—Constipation—Epirubicin—liver cancer	0.000255	0.000735	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000252	0.000724	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—liver cancer	0.00025	0.000719	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—liver cancer	0.000248	0.000714	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—liver cancer	0.000246	0.000709	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—liver cancer	0.000246	0.000708	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—liver cancer	0.000246	0.000707	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—liver cancer	0.000244	0.000703	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—liver cancer	0.000243	0.0007	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—liver cancer	0.00024	0.000691	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000239	0.000686	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—liver cancer	0.000238	0.000686	CcSEcCtD
Propafenone—Urticaria—Epirubicin—liver cancer	0.000237	0.000683	CcSEcCtD
Propafenone—Pain—Doxorubicin—liver cancer	0.000236	0.00068	CcSEcCtD
Propafenone—Constipation—Doxorubicin—liver cancer	0.000236	0.00068	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—liver cancer	0.000236	0.000679	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—liver cancer	0.000236	0.000679	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—liver cancer	0.000228	0.000655	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000226	0.00065	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—liver cancer	0.00022	0.000633	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—liver cancer	0.00022	0.000632	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—liver cancer	0.000218	0.000629	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—liver cancer	0.000218	0.000629	CcSEcCtD
Propafenone—Asthenia—Epirubicin—liver cancer	0.000214	0.000617	CcSEcCtD
Propafenone—Pruritus—Epirubicin—liver cancer	0.000211	0.000608	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—liver cancer	0.000204	0.000588	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—liver cancer	0.000204	0.000586	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—liver cancer	0.000198	0.000571	CcSEcCtD
Propafenone—Dizziness—Epirubicin—liver cancer	0.000198	0.000568	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—liver cancer	0.000196	0.000563	CcSEcCtD
Propafenone—Vomiting—Epirubicin—liver cancer	0.00019	0.000546	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—liver cancer	0.000189	0.000544	CcSEcCtD
Propafenone—Rash—Epirubicin—liver cancer	0.000188	0.000542	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—liver cancer	0.000188	0.000541	CcSEcCtD
Propafenone—Headache—Epirubicin—liver cancer	0.000187	0.000538	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—liver cancer	0.000183	0.000526	CcSEcCtD
Propafenone—Nausea—Epirubicin—liver cancer	0.000177	0.00051	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—liver cancer	0.000176	0.000506	CcSEcCtD
Propafenone—Rash—Doxorubicin—liver cancer	0.000174	0.000501	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—liver cancer	0.000174	0.000501	CcSEcCtD
Propafenone—Headache—Doxorubicin—liver cancer	0.000173	0.000498	CcSEcCtD
Propafenone—Nausea—Doxorubicin—liver cancer	0.000164	0.000472	CcSEcCtD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.84e-05	0.000279	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTA4—liver cancer	3.81e-05	0.000277	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.8e-05	0.000276	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—AKT1—liver cancer	3.77e-05	0.000274	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CRABP1—liver cancer	3.72e-05	0.00027	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTA2—liver cancer	3.71e-05	0.00027	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—F2—liver cancer	3.7e-05	0.000269	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTA4—liver cancer	3.59e-05	0.000261	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTA1—liver cancer	3.58e-05	0.000261	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.58e-05	0.00026	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTA4—liver cancer	3.56e-05	0.000259	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.55e-05	0.000258	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NAT2—liver cancer	3.54e-05	0.000258	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CG—liver cancer	3.54e-05	0.000257	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CPT1B—liver cancer	3.51e-05	0.000255	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GLUL—liver cancer	3.51e-05	0.000255	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTA2—liver cancer	3.5e-05	0.000254	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.48e-05	0.000253	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTA2—liver cancer	3.47e-05	0.000252	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CD—liver cancer	3.43e-05	0.000249	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALDOB—liver cancer	3.4e-05	0.000247	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NR1H4—liver cancer	3.38e-05	0.000246	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTA1—liver cancer	3.38e-05	0.000245	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.35e-05	0.000243	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTA1—liver cancer	3.35e-05	0.000243	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NAT2—liver cancer	3.34e-05	0.000243	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTA3—liver cancer	3.33e-05	0.000242	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NAT2—liver cancer	3.31e-05	0.000241	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.26e-05	0.000237	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HPGDS—liver cancer	3.25e-05	0.000236	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CRABP1—liver cancer	3.24e-05	0.000236	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	3.24e-05	0.000236	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.23e-05	0.000235	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALDOB—liver cancer	3.2e-05	0.000233	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.18e-05	0.000231	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALDOB—liver cancer	3.17e-05	0.000231	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.16e-05	0.00023	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PRKCE—liver cancer	3.15e-05	0.000229	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CD—liver cancer	3.11e-05	0.000226	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CRABP1—liver cancer	3.05e-05	0.000222	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTA4—liver cancer	3.04e-05	0.000221	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CRABP1—liver cancer	3.03e-05	0.00022	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CB—liver cancer	2.99e-05	0.000217	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF2—liver cancer	2.98e-05	0.000217	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.97e-05	0.000216	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTA2—liver cancer	2.97e-05	0.000216	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.94e-05	0.000214	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.91e-05	0.000211	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PSMA4—liver cancer	2.9e-05	0.000211	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PSMD10—liver cancer	2.9e-05	0.000211	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTA1—liver cancer	2.86e-05	0.000208	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HPGDS—liver cancer	2.83e-05	0.000206	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NAT2—liver cancer	2.83e-05	0.000206	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GOT2—liver cancer	2.82e-05	0.000205	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CSF2—liver cancer	2.78e-05	0.000202	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—RAF1—liver cancer	2.78e-05	0.000202	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—H2AFX—liver cancer	2.74e-05	0.000199	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2—liver cancer	2.74e-05	0.000199	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.73e-05	0.000198	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.72e-05	0.000198	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALDOB—liver cancer	2.71e-05	0.000197	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CB—liver cancer	2.71e-05	0.000197	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CPT1B—liver cancer	2.71e-05	0.000197	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GLUL—liver cancer	2.71e-05	0.000197	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HPGDS—liver cancer	2.67e-05	0.000194	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.67e-05	0.000194	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP2E1—liver cancer	2.65e-05	0.000193	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HPGDS—liver cancer	2.65e-05	0.000192	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.63e-05	0.000191	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NR1H4—liver cancer	2.61e-05	0.00019	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CRABP1—liver cancer	2.59e-05	0.000188	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA3—liver cancer	2.57e-05	0.000187	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.57e-05	0.000187	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PSMD10—liver cancer	2.53e-05	0.000184	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PSMA4—liver cancer	2.53e-05	0.000184	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—liver cancer	2.49e-05	0.000181	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TERT—liver cancer	2.48e-05	0.00018	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYCS—liver cancer	2.48e-05	0.00018	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GOT2—liver cancer	2.46e-05	0.000179	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GGT1—liver cancer	2.43e-05	0.000177	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GOT1—liver cancer	2.43e-05	0.000177	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.41e-05	0.000175	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.4e-05	0.000174	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PSMA4—liver cancer	2.38e-05	0.000173	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PSMD10—liver cancer	2.38e-05	0.000173	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.37e-05	0.000172	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PSMA4—liver cancer	2.36e-05	0.000171	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PSMD10—liver cancer	2.36e-05	0.000171	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA4—liver cancer	2.35e-05	0.000171	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.33e-05	0.000169	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GOT2—liver cancer	2.31e-05	0.000168	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP2E1—liver cancer	2.31e-05	0.000168	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GOT2—liver cancer	2.29e-05	0.000167	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA2—liver cancer	2.29e-05	0.000166	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KDR—liver cancer	2.27e-05	0.000165	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HPGDS—liver cancer	2.26e-05	0.000164	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK14—liver cancer	2.25e-05	0.000164	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.25e-05	0.000163	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—liver cancer	2.21e-05	0.000161	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTA1—liver cancer	2.21e-05	0.00016	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTP1—liver cancer	2.19e-05	0.000159	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—F2—liver cancer	2.18e-05	0.000159	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NAT2—liver cancer	2.18e-05	0.000159	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.18e-05	0.000158	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP2E1—liver cancer	2.18e-05	0.000158	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYCS—liver cancer	2.16e-05	0.000157	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP2E1—liver cancer	2.16e-05	0.000157	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMOX1—liver cancer	2.16e-05	0.000157	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GGT1—liver cancer	2.12e-05	0.000154	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GOT1—liver cancer	2.12e-05	0.000154	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDOB—liver cancer	2.09e-05	0.000152	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APC—liver cancer	2.09e-05	0.000152	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CG—liver cancer	2.09e-05	0.000152	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.09e-05	0.000152	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.05e-05	0.000149	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYCS—liver cancer	2.04e-05	0.000148	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.02e-05	0.000147	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYCS—liver cancer	2.02e-05	0.000147	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMD10—liver cancer	2.02e-05	0.000147	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMA4—liver cancer	2.02e-05	0.000147	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—liver cancer	2.01e-05	0.000146	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GOT1—liver cancer	2e-05	0.000145	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GGT1—liver cancer	2e-05	0.000145	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CRABP1—liver cancer	2e-05	0.000145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GGT1—liver cancer	1.98e-05	0.000144	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GOT1—liver cancer	1.98e-05	0.000144	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BRAF—liver cancer	1.96e-05	0.000143	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GOT2—liver cancer	1.96e-05	0.000143	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—liver cancer	1.9e-05	0.000138	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A1—liver cancer	1.9e-05	0.000138	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—liver cancer	1.88e-05	0.000137	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2E1—liver cancer	1.84e-05	0.000134	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CD—liver cancer	1.84e-05	0.000134	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—liver cancer	1.82e-05	0.000132	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SERPINE1—liver cancer	1.82e-05	0.000132	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KRAS—liver cancer	1.8e-05	0.000131	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—liver cancer	1.79e-05	0.00013	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.79e-05	0.00013	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—liver cancer	1.78e-05	0.000129	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—liver cancer	1.78e-05	0.000129	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—liver cancer	1.77e-05	0.000129	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—liver cancer	1.75e-05	0.000128	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—liver cancer	1.75e-05	0.000127	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HPGDS—liver cancer	1.75e-05	0.000127	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARA—liver cancer	1.74e-05	0.000127	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYCS—liver cancer	1.73e-05	0.000125	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GGT1—liver cancer	1.69e-05	0.000123	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GOT1—liver cancer	1.69e-05	0.000123	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A1—liver cancer	1.66e-05	0.000121	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—liver cancer	1.65e-05	0.00012	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—liver cancer	1.65e-05	0.00012	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAF1—liver cancer	1.64e-05	0.000119	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—liver cancer	1.64e-05	0.000119	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MTOR—liver cancer	1.6e-05	0.000116	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CB—liver cancer	1.6e-05	0.000116	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.56e-05	0.000114	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A1—liver cancer	1.56e-05	0.000114	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMD10—liver cancer	1.56e-05	0.000113	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMA4—liver cancer	1.56e-05	0.000113	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A1—liver cancer	1.55e-05	0.000113	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—liver cancer	1.55e-05	0.000112	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRAS—liver cancer	1.53e-05	0.000111	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—liver cancer	1.52e-05	0.000111	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARA—liver cancer	1.52e-05	0.00011	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GOT2—liver cancer	1.51e-05	0.00011	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1B—liver cancer	1.5e-05	0.000109	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—liver cancer	1.5e-05	0.000109	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CG—liver cancer	1.49e-05	0.000108	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—liver cancer	1.49e-05	0.000108	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—liver cancer	1.47e-05	0.000107	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—liver cancer	1.46e-05	0.000106	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—liver cancer	1.46e-05	0.000106	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—liver cancer	1.45e-05	0.000105	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—liver cancer	1.44e-05	0.000105	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—liver cancer	1.43e-05	0.000104	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JUN—liver cancer	1.43e-05	0.000104	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARA—liver cancer	1.43e-05	0.000104	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2E1—liver cancer	1.42e-05	0.000103	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CTNNB1—liver cancer	1.42e-05	0.000103	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARA—liver cancer	1.42e-05	0.000103	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—liver cancer	1.4e-05	0.000102	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—liver cancer	1.39e-05	0.000101	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1A—liver cancer	1.39e-05	0.000101	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK8—liver cancer	1.35e-05	9.84e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—liver cancer	1.35e-05	9.81e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYCS—liver cancer	1.33e-05	9.68e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1A1—liver cancer	1.32e-05	9.63e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CD—liver cancer	1.31e-05	9.53e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GGT1—liver cancer	1.31e-05	9.5e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GOT1—liver cancer	1.31e-05	9.5e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CG—liver cancer	1.3e-05	9.45e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—liver cancer	1.29e-05	9.41e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.27e-05	9.26e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—liver cancer	1.25e-05	9.12e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—liver cancer	1.25e-05	9.09e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—liver cancer	1.24e-05	9e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—liver cancer	1.23e-05	8.98e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CG—liver cancer	1.22e-05	8.9e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CG—liver cancer	1.21e-05	8.82e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARA—liver cancer	1.21e-05	8.81e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—liver cancer	1.18e-05	8.59e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—liver cancer	1.17e-05	8.53e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—liver cancer	1.17e-05	8.52e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—liver cancer	1.16e-05	8.41e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—liver cancer	1.15e-05	8.36e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—liver cancer	1.15e-05	8.34e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CB—liver cancer	1.14e-05	8.31e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CD—liver cancer	1.14e-05	8.3e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—liver cancer	1.13e-05	8.2e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.09e-05	7.91e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—liver cancer	1.08e-05	7.84e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CD—liver cancer	1.08e-05	7.83e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CD—liver cancer	1.07e-05	7.76e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KRAS—liver cancer	1.06e-05	7.73e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—liver cancer	1.06e-05	7.73e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—liver cancer	1.05e-05	7.66e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CG—liver cancer	1.04e-05	7.54e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A1—liver cancer	1.02e-05	7.43e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—liver cancer	1e-05	7.28e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CB—liver cancer	9.96e-06	7.24e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—liver cancer	9.76e-06	7.1e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—liver cancer	9.53e-06	6.93e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—liver cancer	9.45e-06	6.87e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CB—liver cancer	9.38e-06	6.82e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARA—liver cancer	9.35e-06	6.8e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CB—liver cancer	9.3e-06	6.76e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CD—liver cancer	9.12e-06	6.63e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRAS—liver cancer	9.03e-06	6.57e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—liver cancer	9e-06	6.54e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—liver cancer	8.65e-06	6.28e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CG—liver cancer	8.01e-06	5.82e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—liver cancer	7.98e-06	5.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CB—liver cancer	7.95e-06	5.78e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—liver cancer	7.73e-06	5.62e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CD—liver cancer	7.04e-06	5.12e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—liver cancer	6.97e-06	5.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—liver cancer	6.95e-06	5.05e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CB—liver cancer	6.14e-06	4.46e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—liver cancer	6.07e-06	4.41e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—liver cancer	5.72e-06	4.16e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—liver cancer	5.69e-06	4.14e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—liver cancer	5.67e-06	4.12e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—liver cancer	4.96e-06	3.6e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—liver cancer	4.85e-06	3.52e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—liver cancer	4.67e-06	3.4e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—liver cancer	4.63e-06	3.37e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—liver cancer	3.96e-06	2.88e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—liver cancer	3.74e-06	2.72e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—liver cancer	3.06e-06	2.22e-05	CbGpPWpGaD
